NEWS

2022914

PR Heartseed recognized as the "Most Promising Pipelines (iPSC Therapy) Award" at the APAC Cell and Gene Therapy Excellent Awards 2022.

2022630

Congress Keiichi Fukuda, CEO at Heartseed is speaking at this year's Cell & Gene Therapy World Asia Summit in September 15-16.

2022620

Media Interview with Keiichi Fukuda was published in "Features", Keio University School of Medicine.

2022614

Congress Takehiko Kaneko, CMO at Heartseed, is speaking at this year's webinar by American Physiological Society.

2022614

Congress Takehiko Kaneko, CMO and Head of R&D at Heartseed, is speaking at this year's iPSC Manufacturing Summit in July 26-28.

202267

Media Interview with Takehiko Kaneko, CMO and Head of R&D at Heartseed, was published in RegMedNet.

2022128

Media Heartseed was featured by NHK World's CATCH JAPAN.

2022111

Media An interview with Kikuo Yasui, COO was published in Venture Valuation.

20211124

Media Featured Story on Heartseed was listed on Science Japan by Japan Science and Technology Agency (JST).
"Developing a next-generation therapy for severe heart failure using iPS cells"

2021810

PR Heartseed named "Ministry of Education, Culture, Sports, Science and Technology (MEXT) Award" at Academic Startups 2021

1 2 3 4